Publications dans lesquelles il/elle collabore avec Julio Núñez Villota (21)

2024

  1. Combinational Diuretics in Heart Failure

    Current Heart Failure Reports, Vol. 21, Núm. 4, pp. 1-11

  2. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  3. Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease

    Clinical Kidney Journal, Vol. 17, Núm. 6

  4. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  5. Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute Heart Failure

    JACC: Heart Failure, Vol. 12, Núm. 2, pp. 304-318

  6. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure

    ESC Heart Failure, Vol. 11, Núm. 3, pp. 1739-1747

  7. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry

    Revista espanola de cardiologia (English ed.), Vol. 77, Núm. 1, pp. 50-59

  8. Trajectory of Urine Albumin-Creatinine Ratio in Patients with Acute Heart Failure

    Cardiorenal medicine

  9. Usefulness of Antigen Carbohydrate 125 and N-Terminal Pro-B-Type Natriuretic Peptide for Assessing Congestion in Chronic Heart Failure: Insights from the CARDIOREN Registry

    Cardiorenal medicine, Vol. 14, Núm. 1, pp. 543-555

2023

  1. Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  2. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry

    Revista Espanola de Cardiologia

  3. Prognostic significance of plasma chloride in elderly patients hospitalized for acute heart failure

    ESC Heart Failure, Vol. 10, Núm. 4, pp. 2637-2647

  4. Usefulness of urinary potassium to creatinine ratio to predict diuretic response in patients with acute heart failure and preserved ejection fraction

    Clinical Cardiology, Vol. 46, Núm. 8, pp. 906-913

2022

  1. Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm

    Revista Portuguesa de Cardiologia, Vol. 41, Núm. 10, pp. 853-861

  2. Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction

    Medicina Clinica, Vol. 159, Núm. 4, pp. 164-170

  3. Comparison of chlorthalidone and spironolactone as additional diuretic therapy in patients with acute heart failure and preserved ejection fraction

    European Heart Journal: Acute Cardiovascular Care, Vol. 11, Núm. 4, pp. 350-355

  4. Respuesta

    Medicina clinica

2021

  1. Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure

    Medicina Clinica, Vol. 156, Núm. 12, pp. 589-594

  2. Iron deficiency and short-term adverse events in patients with decompensated heart failure

    Clinical Research in Cardiology, Vol. 110, Núm. 8, pp. 1292-1298

  3. Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis

    European Journal of Internal Medicine